Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (391-400 of 560) with videos related to

Pageof 56
Sort By:
The Journal of Allergy and Clinical Immunology|September 19, 2022
Azathioprine therapy induces selective NK cell depletion and IFN-γ deficiency predisposing to herpesvirus reactivationFlorian Ingelfinger, Colin Sparano, David Bamert, et al.
Journal of the National Cancer Institute|January 18, 2012
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trialJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2006
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamideJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Cancer Treatment Reviews|March 6, 2025
Current controversies in the use of Oncotype DX in early breast cancerPier Paolo M Berton Giachetti, Ambra Carnevale Schianca, Dario Trapani, et al.
Eclinicalmedicine|December 2, 2024
Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic reviewSusanne Osanto, Anne-Laurien van de Vliert-Bout, Cristina Alvarez Gomez de Segura, et al.
Vaccines|June 25, 2026
Exploring the World, Minimizing Risks: Travelers' Awareness and Risk Perception of Infectious Diseases in the Post-Pandemic EraRosa Katia Bellomo, Maria Assunta Donato, Vito Cerabona, et al.
Annals of Hematology|October 9, 2025
Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA surveyLeonardo Potenza, Fabio Efficace, Eleonora Borelli, et al.
American Journal of Clinical Pathology|May 20, 2014
CD90 expression in atypical meningiomas and meningioma metastasisGiosuè Scognamiglio, Antonio D'Antonio, Giulio Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancerBryan P Schneider, Fengmin Zhao, Molin Wang, et al.
Cancer|August 29, 2012
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancerJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Pageof 56

Showing results (391-400 of 560) with videos related to

Sort By:
Pageof 56
The Journal of Allergy and Clinical Immunology|September 19, 2022
Azathioprine therapy induces selective NK cell depletion and IFN-γ deficiency predisposing to herpesvirus reactivationFlorian Ingelfinger, Colin Sparano, David Bamert, et al.
Journal of the National Cancer Institute|January 18, 2012
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trialJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2006
Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamideJoseph A Sparano, Stacy Moulder, Aslamuzzaman Kazi, et al.
Cancer Treatment Reviews|March 6, 2025
Current controversies in the use of Oncotype DX in early breast cancerPier Paolo M Berton Giachetti, Ambra Carnevale Schianca, Dario Trapani, et al.
Eclinicalmedicine|December 2, 2024
Health-related quality of life outcomes in randomized controlled trials in metastatic hormone-sensitive prostate cancer: a systematic reviewSusanne Osanto, Anne-Laurien van de Vliert-Bout, Cristina Alvarez Gomez de Segura, et al.
Vaccines|June 25, 2026
Exploring the World, Minimizing Risks: Travelers' Awareness and Risk Perception of Infectious Diseases in the Post-Pandemic EraRosa Katia Bellomo, Maria Assunta Donato, Vito Cerabona, et al.
Annals of Hematology|October 9, 2025
Understanding challenges and barriers to quality end-of-life care for patients with hematologic malignancies: a GIMEMA surveyLeonardo Potenza, Fabio Efficace, Eleonora Borelli, et al.
American Journal of Clinical Pathology|May 20, 2014
CD90 expression in atypical meningiomas and meningioma metastasisGiosuè Scognamiglio, Antonio D'Antonio, Giulio Rossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancerBryan P Schneider, Fengmin Zhao, Molin Wang, et al.
Cancer|August 29, 2012
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancerJoseph A Sparano, Molin Wang, Fengmin Zhao, et al.
Pageof 56